New CEO has work cut out as AstraZeneca sales fall

Handout photograph of AstraZeneca Chief Executive Pascal SoriotLONDON (Reuters) – AstraZeneca's sales slumped by a bigger-than-expected 19 percent in the third quarter, underscoring the challenges confronting the drugmaker's new chief executive, Pascal Soriot. Faced with patent expiries on once best-selling medicines and a thin pipeline of new drugs, the former Roche executive, who joined on October 1, needs to re-focus operations and step up the hunt for acquisitions, analysts believe. …

Novartis does not expect further sales bans of flu vaccines

ZURICH (Reuters) – The Chief Executive of Swiss drugmaker Novartis is confident its flu vaccines manufactured in Italy are safe and does not expect further countries to ban sales or halt deliveries. In a conference call to journalists, Chief Executive Joseph Jimenez said Novartis shipped the two vaccines produced in Italy to European markets and parts of Asia. He said he did not expect other countries to take action to suspend deliveries but he could not rule this out. Novartis reported worse-than-expected third quarter sales on Thursday, dragged down by the loss of a U.S. …

Novartis sales disappoint as Diovan patent loss bites

The logo of Swiss drugmaker Novartis is seen on the top of an office building at the company's plant in BaselZURICH (Reuters) – Swiss drugmaker Novartis posted lower-than-expected third quarter sales on Thursday, dragged down by the loss of a U.S. patent on its top-selling blood pressure drug Diovan and lower sales at its Sandoz unit. Third-quarter net sales fell 2 percent to $13.807 billion, falling short of the average forecast in a Reuters poll of $14.032 billion, while core earnings per share fell 6 percent to $1.34, in line with consensus. Novartis is facing headwinds from a wave of patent expiries sweeping through the global pharmaceutical industry. …

Obama offers a glimpse of his second-term priorities

U.S. President Barack Obama speaks during a campaign rally in Las VegasDAVENPORT, Iowa (Reuters) – President Barack Obama predicted passage of immigration reform and a deficit-reduction deal, offering a fresh glimpse of his second-term agenda as he fights for votes in the final stretch of the tight race for the White House. In a newspaper interview released on Wednesday ahead of an eight-state campaign blitz that began in Iowa, Obama also suggested Republicans were bolstering his re-election effort by alienating Hispanics ahead of the November 6 vote. …

Man whose wife died of meningitis is hospitalized for same illness

DETROIT (Reuters) – A Michigan man whose wife died of meningitis after receiving injections of potentially tainted steroids is now in a hospital being treated for meningitis, his daughter said on Wednesday. Lilian Cary, 67, who died September 30, is one of two dozen people who have died in an outbreak of fungal meningitis linked to the tainted injections. Now her widower, George Cary, 65, is among more than 300 people who have been stricken with meningitis after receiving the injections. …

U.S. death toll rises to 24 in meningitis outbreak

A sample of Cladosporium species, one of the fungi diagnosed in the fungal meningitis outbreak sweeping the United States, in Nashville, Tennessee(Reuters) – The death toll from a U.S. outbreak of fungal meningitis due to injections of tainted steroid medication has reached 24 with Indiana now reporting a third death, the Centers for Disease Control and Prevention said on Wednesday. Eight new cases of meningitis were reported, pushing the total nationally to 312 cases in 17 states, the CDC said. Five joint infections caused by injections also have been reported, bringing the total number of infections to 317. The number of cases has continued to mount despite the recall of the product by the New England Compounding Center. …

1 18 19 20 21 22 106